Cargando…

Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data

BACKGROUND: Pulmonary hypertension (PH) is a serious complication of chronic obstructive pulmonary disease (COPD). While clinical guidelines recommend specific drug therapies for pulmonary arterial hypertension (PAH), these drug therapies are not recommended for PH due to lung disease. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Tracey J., Rosen Ramey, Dena, Yang, Lingfeng, Liu, Xinyue, Patel, Mahesh J., Rajpathak, Swapnil, Bajwa, Ednan K., Lautsch, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578250/ https://www.ncbi.nlm.nih.gov/pubmed/36258171 http://dx.doi.org/10.1186/s12890-022-02167-9

Ejemplares similares

Healthcare resource utilization in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD): a real-world data analysis
por: Weiss, Tracey, et al.
Publicado: (2023)

Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
por: Lautsch, Dominik, et al.
Publicado: (2019)

Anticoagulant and Antiplatelet Use Among Hemodialysis Patients in the United States Without Medicare
por: Boggs, Robert, et al.
Publicado: (2022)

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin
por: Wehler, Elizabeth, et al.
Publicado: (2020)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
por: Weiss, Tracey, et al.
Publicado: (2021)

The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
por: Bajwa, Abubakr A., et al.
Publicado: (2017)

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States
por: Weiss, Tracey, et al.
Publicado: (2020)

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
por: Weiss, Tracey, et al.
Publicado: (2022)

Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study
por: Tang, Yuexin, et al.
Publicado: (2020)

Pulmonary Hypertension Secondary to COPD
por: Shujaat, Adil, et al.
Publicado: (2012)

Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease
por: Aurangabadkar, Gaurang M, et al.
Publicado: (2022)

Validation of a claims-based algorithm to identify patients with chronic thromboembolic pulmonary hypertension using electronic health record data
por: Teal, Simon, et al.
Publicado: (2018)

Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis
por: Lautsch, Dominik, et al.
Publicado: (2020)

Individualized HbA(1c) Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey
por: Lautsch, Dominik, et al.
Publicado: (2021)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Update on pulmonary hypertension complicating chronic obstructive pulmonary disease
por: Jyothula, Soma, et al.
Publicado: (2009)

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
por: Sun, Wan-Lu, et al.
Publicado: (2019)

The genetics of acute lung injury: looking back and pointing the way forward
por: Bajwa, Ednan K
Publicado: (2009)

A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension
por: Chogtu, Bharti, et al.
Publicado: (2016)

Mechanisms of development of chronic obstructive pulmonary disease-associated pulmonary hypertension
por: Barberà, Joan Albert
Publicado: (2013)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

The role of vitamin D in chronic obstructive pulmonary disease with pulmonary hypertension
por: Li, Mengxi
Publicado: (2023)

Cost-effectiveness of Pulmonary Rehabilitation Among US Adults With Chronic Obstructive Pulmonary Disease
por: Mosher, Christopher L., et al.
Publicado: (2022)

Study of Pulmonary Hypertension in Patients Suffering from Chronic Obstructive Pulmonary Disease
por: TUDORAȘCU, D.R., et al.
Publicado: (2016)

Care of the Surgical ICU Patient with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension
por: Kassutto, Stacey M., et al.
Publicado: (2016)

Relationship between pulmonary artery hemodynamics and right ventricle function in pulmonary arterial hypertension using cardiovascular magnetic resonance
por: Ibrahim, El-Sayed, et al.
Publicado: (2012)

Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
por: Frille, Armin, et al.
Publicado: (2020)

Assessment of Pulmonary Arterial Hypertension by Magnetic Resonance Imaging
por: Ibrahim, El-Sayed H., et al.
Publicado: (2015)

Chronic Obstructive Pulmonary Disease and Arthritis Among US Adults, 2016
por: Liu, Yong, et al.
Publicado: (2019)

Use of Tadalafil for Treating Pulmonary Arterial Hypertension Secondary to Chronic Obstructive Pulmonary Disease
por: Kim, Hyun-Sook, et al.
Publicado: (2007)

The use of iloprost in the treatment of ‘out of proportion’ pulmonary hypertension in chronic obstructive pulmonary disease
por: Lasota, Bartosz, et al.
Publicado: (2013)

A Nomogram for Predicting the Risk of Pulmonary Hypertension for Patients with Chronic Obstructive Pulmonary Disease
por: Wang, Ning, et al.
Publicado: (2022)

Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes
por: Wang, Lixia, et al.
Publicado: (2023)

Value of the neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease complicated with pulmonary hypertension
por: Jiang, Tingting, et al.
Publicado: (2023)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Quantitative Computed Tomography of Pulmonary Emphysema and Ventricular Function in Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension
por: Huang, Yu-Sen, et al.
Publicado: (2014)

Prognostic Interplay Between COVID-19 and Heart Failure With Reduced Ejection Fraction
por: Greene, STEPHEN J., et al.
Publicado: (2022)

Severe Pulmonary Arterial Hypertension: Comprehensive Evaluation by Magnetic Resonance Imaging
por: Ibrahim, El-Sayed H., et al.
Publicado: (2015)

Superiority of pulmonary administration of mepenzolate bromide over other routes as treatment for chronic obstructive pulmonary disease
por: Tanaka, Ken-Ichiro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k1qlglbe0ipl94qu6hvu4e036r